{"latest_checked": "2026-10-13T12:59:55.974392+00:00", "coverage_count": 5027, "intelligence": {"score": 42, "label": "Disposal tilt", "tone": "negative", "stance": "Check participation, transaction context and price together", "brief": "Priced common-share disposals outweigh acquisitions across the participating insiders. Each qualifying company has equal weight in this group reading.", "confidence": 46, "confidence_label": "Purpose not verified", "filings": 42, "companies": 1, "qualified_companies": 1, "insiders": 3, "signal_events": 10, "acquisition_events": 3, "disposal_events": 7, "acquisition_share": 30.0, "disposal_share": 70.0, "acquisition_value": 1101678.72, "disposal_value": 5747142.4, "net_value": -4645463.68, "acquisition_value_label": "$1.1M", "disposal_value_label": "$5.7M", "net_value_label": "-$4.6M", "data_quality": 48, "priced_common_share": 24, "latest_date": "2026-09-11", "latest_signal_date": "2026-09-11", "oldest_date": "2026-07-23", "recent_acquirers": 0, "cluster_companies": 0, "repeat_acquirers": 0, "largest_person_share": 44, "acquisition_companies": 0, "disposal_companies": 1, "method_version": "insider-2.0", "purpose_verified": false, "evidence_classes": [{"key": "common_equity", "label": "Common equity", "count": 29, "bar_width": 100.0}, {"key": "equity_award", "label": "Equity compensation", "count": 0, "bar_width": 0.0}, {"key": "derivative", "label": "Options and derivatives", "count": 13, "bar_width": 44.8}, {"key": "other", "label": "Other securities", "count": 0, "bar_width": 0.0}], "roles": [{"label": "Other executive", "count": 28, "bar_width": 100.0}, {"label": "Director", "count": 10, "bar_width": 35.7}, {"label": "CEO and chair", "count": 2, "bar_width": 7.1}, {"label": "Finance leadership", "count": 2, "bar_width": 7.1}], "supports": ["10 priced common-share events after duplicate controls.", "3 named participants across 1 companies."], "risks": ["Transaction codes, filing dates and trading-plan flags are not supplied. Acquisitions are not verified discretionary purchases.", "The latest usable transaction is more than two weeks old."]}, "freshness": {"total": 5027, "checked": 4982, "errors": 45, "latest": "2026-10-13T12:59:55.974Z", "session": "2026-10-13", "share": 99.1, "pending": 45}, "participation": [{"date": "2026-07-27", "acquirers": 0, "disposers": 0}, {"date": "2026-08-03", "acquirers": 1, "disposers": 2}, {"date": "2026-08-10", "acquirers": 0, "disposers": 1}, {"date": "2026-08-17", "acquirers": 0, "disposers": 0}, {"date": "2026-08-24", "acquirers": 0, "disposers": 0}, {"date": "2026-08-31", "acquirers": 0, "disposers": 0}, {"date": "2026-09-07", "acquirers": 1, "disposers": 1}, {"date": "2026-09-14", "acquirers": 0, "disposers": 0}, {"date": "2026-09-21", "acquirers": 0, "disposers": 0}, {"date": "2026-09-28", "acquirers": 0, "disposers": 0}, {"date": "2026-10-05", "acquirers": 0, "disposers": 0}, {"date": "2026-10-12", "acquirers": 0, "disposers": 0}], "recent_count": 42, "transaction_limit": 160, "filters": {"q": "", "ticker": "IMNM", "sector": "", "industry": "", "side": "", "start": "2026-07-16", "end": "2026-10-13"}, "summary": {"total": 42, "acquisition_count": 18, "disposal_count": 10, "acquisition_value": 1101678.72, "acquisition_value_label": "$1.1M", "disposal_value": 5747142.4, "disposal_value_label": "$5.7M", "net_value": -4645463.68, "net_value_label": "$-4.6M", "flow_tone": "negative", "largest_value_label": "$2.3M", "top_sector": "Healthcare", "window_label": "16 Jul 2026 to 13 Oct 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 42, "value": "13697642.2400", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$13.7M"}], "days": [{"transaction_date": "2026-07-23", "acquisitions": 14, "disposals": 0, "total": 14, "bar_width": 100.0}, {"transaction_date": "2026-08-04", "acquisitions": 2, "disposals": 3, "total": 5, "bar_width": 35.7}, {"transaction_date": "2026-08-06", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-08-07", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-08-10", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-08-11", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-08-12", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 7.1}, {"transaction_date": "2026-09-11", "acquisitions": 2, "disposals": 2, "total": 4, "bar_width": 28.6}], "side_mix": {"acquisitions": 18, "disposals": 10, "acquisition_share": 64.3, "disposal_share": 35.7}}, "company_flows": [{"symbol": "IMNM", "name": "Immunome\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-09-11", "acquisitions": 3, "disposals": 7, "acquired_value": 1101678.72, "acquired_value_label": "$1.1M", "disposed_value": 5747142.4, "disposed_value_label": "$5.7M", "net_value": -4645463.68, "net_value_label": "$-4.6M", "acquisition_share": 30.0, "disposal_share": 70.0, "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}], "company_overview": [{"symbol": "IMNM", "name": "Immunome\u00a0Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-09-11", "filings": 42, "acquisitions": 18, "disposals": 10, "acquired_value": 1101678.72, "acquired_value_label": "$1.1M", "disposed_value": 5747142.4, "disposed_value_label": "$5.7M", "net_value": -4645463.68, "net_value_label": "$-4.6M", "acquisition_share": 64.3, "disposal_share": 35.7, "tone": "Net acquisition", "tone_class": "positive", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}], "transactions": [{"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "G", "side": "G", "shares": 8800.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "M", "side": "M", "shares": 18000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 18000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 8800.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 13200.0, "share_price": 25.32, "transaction_value": 334224.0, "transaction_value_label": "$334.2K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 13200.0, "share_price": 25.32, "transaction_value": 334224.0, "transaction_value_label": "$334.2K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 18000.0, "share_price": 1.35, "transaction_value": 24300.0, "transaction_value_label": "$24.3K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-09-11", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "M", "side": "M", "shares": 18000.0, "share_price": 1.35, "transaction_value": 24300.0, "transaction_value_label": "$24.3K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-12", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11048.0, "share_price": 27.25, "transaction_value": 301058.0, "transaction_value_label": "$301.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-12", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 11048.0, "share_price": 27.25, "transaction_value": 301058.0, "transaction_value_label": "$301.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-11", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 62291.0, "share_price": 26.23, "transaction_value": 1633892.93, "transaction_value_label": "$1.6M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-11", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 62291.0, "share_price": 26.23, "transaction_value": 1633892.93, "transaction_value_label": "$1.6M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-10", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 10125.0, "share_price": 26.07, "transaction_value": 263958.75, "transaction_value_label": "$264.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-10", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10125.0, "share_price": 26.07, "transaction_value": 263958.75, "transaction_value_label": "$264.0K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-07", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 15248.0, "share_price": 26.06, "transaction_value": 397362.88, "transaction_value_label": "$397.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-07", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 15248.0, "share_price": 26.06, "transaction_value": 397362.88, "transaction_value_label": "$397.4K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-06", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 20840.0, "share_price": 26.06, "transaction_value": 543090.4, "transaction_value_label": "$543.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-06", "executive": "BARCHAS, ISAAC", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 20840.0, "share_price": 26.06, "transaction_value": 543090.4, "transaction_value_label": "$543.1K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Employee Stock Option (right to buy)", "side_code": "M", "side": "M", "shares": 40250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 40250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Employee Stock Option (right to buy)", "side_code": "M", "side": "M", "shares": 50366.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Employee Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 50366.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "S", "side": "S", "shares": 90616.0, "share_price": 25.09, "transaction_value": 2273555.44, "transaction_value_label": "$2.3M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 90616.0, "share_price": 25.09, "transaction_value": 2273555.44, "transaction_value_label": "$2.3M", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 50366.0, "share_price": 12.92, "transaction_value": 650728.72, "transaction_value_label": "$650.7K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "M", "side": "M", "shares": 50366.0, "share_price": 12.92, "transaction_value": 650728.72, "transaction_value_label": "$650.7K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "M", "side": "M", "shares": 40250.0, "share_price": 10.6, "transaction_value": 426650.0, "transaction_value_label": "$426.6K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-08-04", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 40250.0, "share_price": 10.6, "transaction_value": 426650.0, "transaction_value_label": "$426.6K", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Priced common-share proxy", "fetched_at": "2026-10-08T09:48:34.246334+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 76500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "HIGGINS, JACK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 38250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 62500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "HORN, KINNEY", "executive_title": "CHIEF BUSINESS OFFICER", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 31250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LECHLEIDER, ROBERT", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 54000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "LECHLEIDER, ROBERT", "executive_title": "Chief Medical Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 108000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "ROSETT, MAX", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 47250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "ROSETT, MAX", "executive_title": "Chief Financial Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 94500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "SIEGALL, CLAY B", "executive_title": "Director, President and CEO", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 180000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "SIEGALL, CLAY B", "executive_title": "Director, President and CEO", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 360000.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "STONEMAN, SANDRA G.", "executive_title": "CHIEF LEGAL OFFICER & GC", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 38250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "STONEMAN, SANDRA G.", "executive_title": "CHIEF LEGAL OFFICER & GC", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 76500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "TSAI, PHILIP", "executive_title": "Chief Technical Officer", "security_type": "Employee Stock Option (right to buy)", "side_code": "A", "side": "Acquisition", "shares": 76500.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "derivative", "evidence_class_label": "Options and derivatives", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}, {"symbol": "IMNM", "name": "Immunome\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-23", "executive": "TSAI, PHILIP", "executive_title": "Chief Technical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 38250.0, "share_price": 0.0, "transaction_value": null, "transaction_value_label": "Not reported", "evidence_class": "common_equity", "evidence_class_label": "Common equity", "evidence_quality": "Context only", "fetched_at": "2026-10-13T09:49:55.407485+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/imnm/", "research_links": {"chart": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/", "report": "/terminal/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/report/", "factor": "/factors/ticker/c3a1b4db-d1a5-47db-9ae2-1b33c6761682/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}